Soleno Therapeutics (SLNO) Amortizatization of Intangibles (2015 - 2026)
Soleno Therapeutics (SLNO) reported Amortizatization of Intangibles of $221000.0 for Q1 2026, down 77.45% year-over-year from $980000.0 in Q1 2025, and down 81.46% quarter-over-quarter from $1.2 million in Q4 2025.
Soleno Therapeutics (SLNO) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 4 years of Amortizatization of Intangibles data on file, last reported at $221000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $221000.0, down 77.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (down 48.94% YoY), and the FY2025 annual result was $3.5 million, down 28.15% from the prior year.
- Amortizatization of Intangibles declined to $221000.0 in Q1 2026 per SLNO's latest filing, from $1.2 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.9 million in Q3 2024 and troughed at $221000.0 in Q1 2026.
- A 3-year average of $959222.2 and a median of $980000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 107.19% in 2025 and fell as far as 80.57% in 2025.
- A 3-year view of Amortizatization of Intangibles shows it stood at $1.4 million in 2024, then dropped by 14.86% to $1.2 million in 2025, then slumped by 81.46% to $221000.0 in 2026.
- Business Quant data shows SLNO's Amortizatization of Intangibles at $221000.0 in Q1 2026, $1.2 million in Q4 2025, and $371000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 221,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 371,000.00 |
| Sep 30, 2025 | 371,000.00 |
| Jun 30, 2025 | 974,000.00 |
| Jun 30, 2025 | 974,000.00 |
| Mar 31, 2025 | 980,000.00 |
| Mar 31, 2025 | 980,000.00 |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 473,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2015 | -11,000.00 |
| Dec 31, 2015 | -11,000.00 |